In September 2024, a readout from a separate trial of rocatinlimab elicited mixed reactions from analysts, who found the ...
As sales of its COVID vaccine plummet, Novavax is looking ahead toward other novel vaccines, brought to market with the help ...
The biotechnology sector has faced a spike in bankruptcy filings over the last two years which has begun to carry over into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback